Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2015 1
2016 3
2017 2
2018 5
2019 6
2020 8
2021 5
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Fluoropyrimidine-induced cardiotoxicity.
Depetris I, Marino D, Bonzano A, Cagnazzo C, Filippi R, Aglietta M, Leone F. Depetris I, et al. Among authors: cagnazzo c. Crit Rev Oncol Hematol. 2018 Apr;124:1-10. doi: 10.1016/j.critrevonc.2018.02.002. Epub 2018 Feb 7. Crit Rev Oncol Hematol. 2018. PMID: 29548480 Review.
Adoptive immunotherapy against ovarian cancer.
Mittica G, Capellero S, Genta S, Cagnazzo C, Aglietta M, Sangiolo D, Valabrega G. Mittica G, et al. Among authors: cagnazzo c. J Ovarian Res. 2016 May 17;9(1):30. doi: 10.1186/s13048-016-0236-9. J Ovarian Res. 2016. PMID: 27188274 Free PMC article. Review.
Biliary tract carcinomas: from chemotherapy to targeted therapy.
Marino D, Leone F, Cavalloni G, Cagnazzo C, Aglietta M. Marino D, et al. Among authors: cagnazzo c. Crit Rev Oncol Hematol. 2013 Feb;85(2):136-48. doi: 10.1016/j.critrevonc.2012.06.006. Epub 2012 Jul 17. Crit Rev Oncol Hematol. 2013. PMID: 22809696 Review.
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial.
Morano F, Raimondi A, Pagani F, Lonardi S, Salvatore L, Cremolini C, Murgioni S, Randon G, Palermo F, Antonuzzo L, Pella N, Racca P, Prisciandaro M, Niger M, Corti F, Bergamo F, Zaniboni A, Ratti M, Palazzo M, Cagnazzo C, Calegari MA, Marmorino F, Capone I, Conca E, Busico A, Brich S, Tamborini E, Perrone F, Di Maio M, Milione M, Di Bartolomeo M, de Braud F, Pietrantonio F. Morano F, et al. Among authors: cagnazzo c. J Clin Oncol. 2022 May 10;40(14):1562-1573. doi: 10.1200/JCO.21.02583. Epub 2022 Mar 8. J Clin Oncol. 2022. PMID: 35258987 Free PMC article. Clinical Trial.
[Clinical research coordinators: a crucial resource.].
Cagnazzo C, Testoni S, Guarrera AS, Stabile S, Taverniti C, Federici I, Pirondi S, Monti M. Cagnazzo C, et al. Recenti Prog Med. 2019 Feb;110(2):65-67. doi: 10.1701/3112.31000. Recenti Prog Med. 2019. PMID: 30843530 Italian.
[Clinical research: enough players to get out there?].
Cagnazzo C, Guarrera A, Cenna R, Taverniti C, Stabile S, Federici I, Pirondi S, Testoni S, Monti M. Cagnazzo C, et al. Recenti Prog Med. 2019 Jun;110(6):285-291. doi: 10.1701/3182.31609. Recenti Prog Med. 2019. PMID: 31282484 Italian.
36 results